928063-31-4

Basic information

• Product Name: 3-(benzyloxycarbonylamino)-4-cyclobutyl-2-hydroxybutanoic acid
• Synonyms: 3-(benzyloxycarbonylamino)-4-cyclobutyl-2-hydroxybutanoic acid
• CAS NO: 928063-31-4
• Molecular Weight: 307.346
• Mol File: 928063-31-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-(benzyloxycarbonylamino)-4-cyclobutyl-2-hydroxybutanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(benzyloxycarbonylamino)-4-cyclobutyl-2-hydroxybutanoic acid(928063-31-4)
• EPA Substance Registry System: 3-(benzyloxycarbonylamino)-4-cyclobutyl-2-hydroxybutanoic acid(928063-31-4)

Safety Data

• Hazardous Substances Data: 928063-31-4(Hazardous Substances Data)

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 1232691-89-2 C₈H₁₅NO₃*ClH 
• 23776-85-4 N-(phenylacetyl)oxysuccinimide 

Downstream Products

• 928063-34-7 benzyl 1-cyclobutyl-4-(cyclopropylamino)-3-hydroxy-4-oxobutan-2-ylcarbamate 
• 928063-33-6 benzyl 1-cyclobutyl-3-hydroxy-4-(methylamino)-4-oxobutan-2-ylcarbamate 

Relevant articles and documents

Inhibitors of Serine Proteases

The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.

INHIBITORS OF SERINE PROTEASES

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.